Domača stranN1BI34 • BVMF
add
Neurocrine Biosciences Bdr
Prejšnji trg. dan.
37,77 R$
Dnevni razpon
37,48 R$ - 38,32 R$
Letni razpon
25,64 R$ - 44,95 R$
Tržna kapitalizacija
14,14 mrd. USD
Povprečni obseg
827,00
Razm. P/E
-
Dividendna donosnost
-
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 794,90 mio. | 27,78 % |
Stroški poslovanja | 291,60 mio. | 24,46 % |
Čisti dohodek | 209,50 mio. | 61,40 % |
Čista dobičkovnost prihodkov | 26,36 | 26,37 % |
Earnings per share | 2,17 | 19,89 % |
EBITDA | 247,00 mio. | 29,12 % |
Efektivna davčna stopnja | 28,20 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,11 mrd. | −9,22 % |
Skupna sredstva | 4,27 mrd. | 20,67 % |
Skupne obveznosti | 1,26 mrd. | 54,65 % |
Celoten lastniški kapital | 3,00 mrd. | — |
Shares outstanding | 99,71 mio. | — |
Razmerje P/B | 1,25 | — |
Donosnost sredstev | 14,67 % | — |
Donosnost kapitala | 17,95 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 209,50 mio. | 61,40 % |
Denar iz dejavnosti | 227,50 mio. | 43,99 % |
Denar iz naložb | −196,70 mio. | −896,36 % |
Denar iz financiranja | 45,60 mio. | 72,73 % |
Neto sprememba denarnih sredstev | 76,20 mio. | −63,61 % |
Prost denarni tok | −35,14 mio. | −237,86 % |
Vizitka
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia.
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
Generalni direktor
Datum ustanovitve
1992
Sedež organizacije
Spletno mesto
Zaposleni
1.800
